We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.32B
AUM Growth
+$263M
Cap. Flow
+$81.3M
Cap. Flow %
1.53%
Top 10 Hldgs %
24.53%
Holding
923
New
177
Increased
263
Reduced
239
Closed
141

Top Buys

Rank Stock Value
1
JCI icon
Johnson Controls International
JCI
+$26.1M
2
RTN
Raytheon Company
RTN
+$22.2M
3
ABT icon
Abbott
ABT
+$20.8M
4
ELLI
Ellie Mae Inc
ELLI
+$19.9M
5
BURL icon
Burlington
BURL
+$19.2M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$30.8M
2
WP
Worldpay, Inc.
WP
+$19.5M
3
UNP icon
Union Pacific
UNP
+$15.4M
4
DG icon
Dollar General
DG
+$13.1M
5
SBUX icon
Starbucks
SBUX
+$12.3M

Sector Composition

Rank Sector Weight
1 Healthcare 17.66%
2 Technology 16.19%
3 Consumer Discretionary 13.83%
4 Financials 12.22%
5 Industrials 8.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMTX icon
226
Aemetis
AMTX
$119M
$1.57M 0.03%
1,453,131
+68,460
+5% +$115K
UAL icon
227
United Airlines
UAL
$38.4B
$1.55M 0.03%
29,536
-19,925
-40% -$959K
EQM
228
DELISTED
EQM Midstream Partners, LP
EQM
$1.53M 0.03%
20,112
-210
-1% -$16.4K
PX
229
DELISTED
Praxair Inc
PX
$1.52M 0.03%
12,551
– –
LKQ icon
230
LKQ Corp
LKQ
$6.58B
$1.51M 0.03%
42,460
-1,808
-4% -$62.7K
ROP icon
231
Roper Technologies
ROP
$36.3B
$1.48M 0.03%
8,123
-1,692
-17% -$295K
SCCO icon
232
Southern Copper
SCCO
$141B
$1.45M 0.03%
59,358
+11,955
+25% +$289K
LGND icon
233
Ligand Pharmaceuticals
LGND
$6.02B
$1.44M 0.03%
22,601
+6,964
+45% +$511K
CAT icon
234
Caterpillar
CAT
$409B
$1.4M 0.03%
15,803
-4,803
-23% -$393K
NJ
235
DELISTED
NIDEC CP (NIHON KABUSHIKI KAISHA)1 ADS REPTG .25 SH COM STK
NJ
$1.4M 0.03%
61,015
-1,440
-2% -$33K
ENV
236
DELISTED
ENVESTNET, INC.
ENV
$1.38M 0.03%
37,942
+704
+2% +$26.7K
RIO icon
237
Rio Tinto
RIO
$148B
$1.37M 0.03%
41,038
+1,975
+5% +$62.9K
DCM
238
DELISTED
NTT DOCOMO, Inc.
DCM
$1.37M 0.03%
53,740
+155
+0.3% +$4.09K
TROW icon
239
T. Rowe Price
TROW
$25B
$1.36M 0.03%
20,421
+35
+0.2% +$2.44K
NUVA
240
DELISTED
NuVasive, Inc.
NUVA
$1.35M 0.03%
20,280
+740
+4% +$47.1K
IEV icon
241
iShares Europe ETF
IEV
$1.63B
$1.35M 0.03%
34,205
+341
+1% +$13.2K
NSC icon
242
Norfolk Southern
NSC
$78.8B
$1.33M 0.03%
13,753
+125
+0.9% +$11.4K
UNH icon
243
UnitedHealth
UNH
$382B
$1.33M 0.03%
9,507
-196
-2% -$27.5K
CEB
244
DELISTED
CEB Inc.
CEB
$1.32M 0.02%
24,289
-549
-2% -$32.8K
VEEV icon
245
Veeva Systems
VEEV
$30.3B
$1.32M 0.02%
31,985
+8,115
+34% +$315K
AMGN icon
246
Amgen
AMGN
$203B
$1.31M 0.02%
7,883
+249
+3% +$42.1K
CL icon
247
Colgate-Palmolive
CL
$72.6B
$1.29M 0.02%
17,446
-50
-0.3% -$3.7K
WAGE
248
DELISTED
WageWorks, Inc.
WAGE
$1.29M 0.02%
21,212
+437
+2% +$26.8K
BAC icon
249
Bank of America
BAC
$435B
$1.28M 0.02%
81,800
-3,142
-4% -$46.8K
JEF icon
250
Jefferies Financial Group
JEF
$12.9B
$1.28M 0.02%
74,988
– –
8 9
10
11 12

Similar funds

CAM
Capstone Asset Management Houston, Texas $3.6B AUM 20.21% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
DL
Delta Lloyd Amsterdam, Netherlands $3.56B AUM 18.98% 1-Year Est. Return
RBC
Ronald Blue & Co Roswell, Georgia $3.1B AUM 12.82% 1-Year Est. Return
TCM
Tetrem Capital Management Winnipeg, Manitoba, Canada $2.29B AUM 16.55% 1-Year Est. Return
HCM
Holland Capital Management Chicago, Illinois $2.28B AUM 23.08% 1-Year Est. Return
AL
Airain Ltd St. Peter Port, Guernsey $2.26B AUM 12.43% 1-Year Est. Return
AT
Alliance Trust Dundee, Scotland, United Kingdom $1.81B AUM 5.04% 1-Year Est. Return

Geneva Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Geneva Advisors held 923 positions worth $5.32B, up 5.2% from $5.06B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Geneva Advisors's Q3 2016 filing shows 177 new, 263 increased, 239 reduced and 141 closed positions. Its largest new stake was A.O. Smith: 245,940 shares worth $12.1M. The largest sale was Bristol-Myers Squibb, an estimated $30.8M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Geneva Advisors's largest Q3 2016 buy was A.O. Smith: 245,940 shares worth $12.1M.
  • Geneva Advisors added most to Johnson Controls International in Q3 2016, an estimated $26.1M increase.
  • Geneva Advisors's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $30.8M.
  • Geneva Advisors fully exited McKesson in Q3 2016, selling an estimated $6.69M.
  • Geneva Advisors's ten largest holdings make up 25% of its $5.32B portfolio in Q3 2016.
  • Geneva Advisors opened 177 new positions and closed 141 in Q3 2016.
  • Geneva Advisors's portfolio value rose 5.2% quarter-over-quarter to $5.32B.

Based on Geneva Advisors's 13F filing for Q3 2016, filed 9 Nov 2016.